JP2019526549A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019526549A5 JP2019526549A5 JP2019507970A JP2019507970A JP2019526549A5 JP 2019526549 A5 JP2019526549 A5 JP 2019526549A5 JP 2019507970 A JP2019507970 A JP 2019507970A JP 2019507970 A JP2019507970 A JP 2019507970A JP 2019526549 A5 JP2019526549 A5 JP 2019526549A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- pharmaceutical composition
- composition according
- carteolol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 15
- 239000008194 pharmaceutical composition Substances 0.000 claims 14
- LWAFSWPYPHEXKX-UHFFFAOYSA-N carteolol Chemical compound N1C(=O)CCC2=C1C=CC=C2OCC(O)CNC(C)(C)C LWAFSWPYPHEXKX-UHFFFAOYSA-N 0.000 claims 6
- 229960001222 carteolol Drugs 0.000 claims 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 5
- 229960001484 edetic acid Drugs 0.000 claims 5
- 239000003889 eye drop Substances 0.000 claims 4
- 229960001126 alginic acid Drugs 0.000 claims 2
- 235000010443 alginic acid Nutrition 0.000 claims 2
- 229920000615 alginic acid Polymers 0.000 claims 2
- 239000000783 alginic acid Substances 0.000 claims 2
- 150000004781 alginic acids Chemical class 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 229940122072 Carbonic anhydrase inhibitor Drugs 0.000 claims 1
- 208000010412 Glaucoma Diseases 0.000 claims 1
- 206010030043 Ocular hypertension Diseases 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 claims 1
- 239000003489 carbonate dehydratase inhibitor Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 230000004410 intraocular pressure Effects 0.000 claims 1
- 239000003002 pH adjusting agent Substances 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 150000003169 prostaglandin F2α derivatives Chemical class 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022127009A JP2022172124A (ja) | 2016-08-23 | 2022-08-09 | 保存効力又は光安定性が改善された点眼用医薬組成物 |
| JP2024077741A JP2024112862A (ja) | 2016-08-23 | 2024-05-13 | 保存効力又は光安定性が改善された点眼用医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016162611 | 2016-08-23 | ||
| JP2016162611 | 2016-08-23 | ||
| PCT/JP2017/029934 WO2018038102A1 (en) | 2016-08-23 | 2017-08-22 | Ophthalmic pharmaceutical composition with improved preservative effectiveness or light stability |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022127009A Division JP2022172124A (ja) | 2016-08-23 | 2022-08-09 | 保存効力又は光安定性が改善された点眼用医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019526549A JP2019526549A (ja) | 2019-09-19 |
| JP2019526549A5 true JP2019526549A5 (enExample) | 2020-08-13 |
| JP7123034B2 JP7123034B2 (ja) | 2022-08-22 |
Family
ID=59812062
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019507970A Active JP7123034B2 (ja) | 2016-08-23 | 2017-08-22 | 保存効力又は光安定性が改善された点眼用医薬組成物 |
| JP2022127009A Pending JP2022172124A (ja) | 2016-08-23 | 2022-08-09 | 保存効力又は光安定性が改善された点眼用医薬組成物 |
| JP2024077741A Pending JP2024112862A (ja) | 2016-08-23 | 2024-05-13 | 保存効力又は光安定性が改善された点眼用医薬組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022127009A Pending JP2022172124A (ja) | 2016-08-23 | 2022-08-09 | 保存効力又は光安定性が改善された点眼用医薬組成物 |
| JP2024077741A Pending JP2024112862A (ja) | 2016-08-23 | 2024-05-13 | 保存効力又は光安定性が改善された点眼用医薬組成物 |
Country Status (4)
| Country | Link |
|---|---|
| JP (3) | JP7123034B2 (enExample) |
| CN (3) | CN115444849B (enExample) |
| TW (4) | TW202332446A (enExample) |
| WO (1) | WO2018038102A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022131565A (ja) * | 2021-02-26 | 2022-09-07 | ロート製薬株式会社 | 水性医薬組成物 |
| CN114788809B (zh) * | 2022-01-25 | 2023-04-14 | 江苏广承药业有限公司 | 一种氯雷他定液体制剂 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01135887A (ja) * | 1987-11-20 | 1989-05-29 | Lion Corp | 紫外線吸収剤組成物 |
| FR2777189B1 (fr) * | 1998-04-09 | 2001-04-06 | Chauvin Lab Sa | Composition ophtalmique comprenant un beta-bloquant |
| JP4361294B2 (ja) * | 2003-02-25 | 2009-11-11 | ロート製薬株式会社 | ケトチフェン含有組成物 |
| JP5711957B2 (ja) * | 2003-09-30 | 2015-05-07 | ロート製薬株式会社 | 透明包装体入りトラニラスト含有医薬製剤 |
| KR20060102282A (ko) * | 2005-03-22 | 2006-09-27 | 테이카 세이야쿠 가부시키가이샤 | 점안제 |
| US20070077302A1 (en) * | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for stabilizing ophthalmic compositions |
| FR2918891B1 (fr) * | 2007-07-20 | 2009-09-25 | Thea Sa Lab | Solution ophtalmique a base de prostaglandines sans conservateur |
| JP5661456B2 (ja) * | 2008-04-23 | 2015-01-28 | 大塚製薬株式会社 | 点眼剤及び使用方法 |
| CN101461780A (zh) | 2009-01-06 | 2009-06-24 | 河北科技大学 | 不含抑菌剂的盐酸卡替洛尔滴眼液及其制备方法 |
| TW201109325A (en) | 2009-07-30 | 2011-03-16 | Wakamoto Pharma Co Ltd | Aqueous composition for eye drops |
| CN103079595B (zh) * | 2010-08-27 | 2015-11-25 | 若素制药株式会社 | 滴眼用水性组合物 |
| CN104136019A (zh) * | 2012-02-27 | 2014-11-05 | 日本乐敦制药株式会社 | 眼科用组合物试剂盒 |
-
2017
- 2017-08-22 TW TW112113506A patent/TW202332446A/zh unknown
- 2017-08-22 TW TW110149715A patent/TWI828025B/zh active
- 2017-08-22 WO PCT/JP2017/029934 patent/WO2018038102A1/en not_active Ceased
- 2017-08-22 CN CN202211127527.1A patent/CN115444849B/zh active Active
- 2017-08-22 CN CN202211126345.2A patent/CN115463130A/zh active Pending
- 2017-08-22 TW TW106128430A patent/TWI814709B/zh active
- 2017-08-22 CN CN201780049806.1A patent/CN109641059B/zh active Active
- 2017-08-22 JP JP2019507970A patent/JP7123034B2/ja active Active
- 2017-08-22 TW TW113131450A patent/TW202513068A/zh unknown
-
2022
- 2022-08-09 JP JP2022127009A patent/JP2022172124A/ja active Pending
-
2024
- 2024-05-13 JP JP2024077741A patent/JP2024112862A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011513492A5 (enExample) | ||
| JP5174777B2 (ja) | Ｒｈｏキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤 | |
| RU2010141542A (ru) | Низковязкие высокофлокулированные суспензии триамцинолона ацетонида для интравитреальных инъекций | |
| RU2012103538A (ru) | Композиции и способы ингибирования пути jak | |
| JP2011516477A5 (enExample) | ||
| JP2009029828A (ja) | Ｒｈｏキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤 | |
| RU2016121150A (ru) | Терапевтическое средство против заболеваний, связанных с гибелью клеток эндотелия роговицы, обусловленной состоянием эндоплазматического ретикулума | |
| JP2017520527A5 (enExample) | ||
| RU2014123472A (ru) | Производные 4-прегенен-11ss-17-21-триол-3,20-диона для лечения глазных болезней | |
| JP2015147762A5 (enExample) | ||
| RU2013142602A (ru) | Композиции и способы для нехирургического лечения птоза | |
| RU2014103544A (ru) | Комбинация фиксированных доз биматопроста и бримонидина | |
| RU2017118405A (ru) | Новое лечение роговицы с применением ламинина | |
| JP2014533274A5 (enExample) | ||
| RU2017116974A (ru) | Офтальмологическая композиция, содержащая циклоспорин и трегалозу | |
| PE20171443A1 (es) | Derivados de carboxamida | |
| CO2020009992A2 (es) | Composiciones oftálmicas que comprenden bilastina, una beta-ciclodextrina y al menos un agente de gelificación | |
| AU2017261303A1 (en) | Ophthalmic compositions | |
| JP2013534527A5 (enExample) | ||
| JP2017186372A5 (enExample) | ||
| JP2019526549A5 (enExample) | ||
| ME02608B (me) | Kombinacija, komplet i postupak snižavanja intraokularnog pritiska | |
| JP2017525758A5 (enExample) | ||
| EA201001326A1 (ru) | Стерильные офтальмологические композиции и способ их получения | |
| RU2018102746A (ru) | Офтальмологическая фармацевтическая композиция |